The board of directors of PD-Rx Pharmaceuticals Inc (OTC:PDRX) Thursday declared its onetime dividend of USD2.20 per share of its stock.
Shareholders of record at the close of business as of 30 November 2018 will receive the dividend on 12 December 2018.
According to the company, it offers pharmaceutical and management strategies to the healthcare industry,with focus on new products, solid business partners and the specialised segment of the pharmaceutical industry.
As a licensed FDA manufacturer and packager, the company offers a full spectrum of medications, specialised services, proprietary products and prepackaged medications that are viewed by patient, insurance payers and healthcare providers as a progressive and responsive practice.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government